Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model

Tianyun Qiao(Air Force Medical University), Yong Han(Air Force Medical University)
Cancer Immunology Immunotherapy
November 10, 2022
Cited by 17


Related Papers